Crossmark Global Holdings, Inc. Vericel Corp Transaction History

Crossmark Global Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 10, 2022	SELL	$35.2 - $52.6 $344,960 - $515,480	-9,800 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$46.35 - $59.75 $454,230 - $585,550	9,800 New	9,800 $478,000
Q3 2021 Oct 13, 2021	SELL	$46.35 - $59.75 $479,259 - $617,815	-10,340 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$47.2 - $67.81 $21,240 - $30,514	-450 Reduced 4.17%	10,340 $543,000
Q1 2021 Apr 15, 2021	BUY	$30.93 - $59.48 $333,734 - $641,789	10,790 New	10,790 $599,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.